Board Meeting Details

The meeting was held at the company's registered office at 6-3-354/13/B2, Flat No. B2, Suryateja Apartments, Hindi Nagar, Punjagutta, Hyderabad-500082, Telangana. The meeting commenced at 3:30 PM and concluded at 4:00 PM.

Items Approved

1. Un-audited Standalone and Consolidated financial results for the quarter ended June 30, 2026

2. Limited Review Reports (Standalone and Consolidated) given by Statutory Auditors for the quarter ended June 30, 2026

Standalone Financial Results (₹ in Lakhs)

For the quarter ended June 30, 2026:

  • Revenue from Operations: 0.00
  • Other Income: 0.00
  • Total Revenue: 0.00
  • Employee benefits expenses: 0.98
  • Finance Costs: 0.00
  • Depreciation and Amortisation expenses: 0.12
  • Other Expenses: 21.55
  • Total Expenses: 31.47
  • Loss before tax: (31.47)
  • Tax Expense: 0.00
  • Loss for the period: (31.47)
  • Other Comprehensive Income: 0.00
  • Total Comprehensive Income for the period: (31.47)
  • Earnings Per Share (Basic and Diluted): (0.14) per share (Face Value INR 10/- each)
  • Paid Up Equity Share Capital: Not specified in standalone results

Consolidated Financial Results (₹ in Lakhs)

For the quarter ended June 30, 2026:

  • Revenue from Operations: 0.00
  • Other Income: 0.00
  • Total Revenue: 0.00
  • Employee benefits expenses: 0.00
  • Depreciation and Amortisation expenses: 0.03
  • Other Expenses: 73.20
  • Total Expenses: 168.30
  • Loss before tax: (11.87)
  • Loss from continuing operations: (11.87)
  • Share of Profit/(loss) of Associates: 12.60
  • Loss for the period: (18.87)
  • Total Comprehensive Income for the period: (18.87)
  • Comprehensive Income attributable to Owners: (18.87)
  • Earnings Per Share (Basic and Diluted): (0.08) per share (Face Value INR 10/- each)
  • Paid Up Equity Share Capital: 2274.97 (Face Value INR 10/- per share)

Comparative Figures

Previous quarter ended March 31, 2026 (Audited):

  • Revenue from Operations: 161.00
  • Other Income: 315.00
  • Total Revenue: 296.00
  • Loss for the period: (48.16)

Previous year ended March 31, 2026 (Audited):

  • Loss for the period: (816.05)

Segment Information

The company has only one reportable segment - Health Care Sector. No separate segment disclosure is required.

Subsidiary and Associate Companies

The company does not have any subsidiaries but has two associate companies:

1. Krisani Bio Sciences Private Limited

2. QROPS Advisory Services Private Limited

The consolidated results include the financial results of these two associate companies. The group's share of profit after tax from associates amounts to ₹12.60 lakh for the quarter ended June 30, 2026.

Auditor Review

Statutory auditors MGR & Co (FRN: 012787S) conducted limited reviews of both standalone and consolidated financial results. The review was performed under SRE 2410 standards. The auditors concluded that nothing has come to their attention that causes them to believe the statements contain any material misstatement.

Accounting Standards

The financial statements have been prepared in accordance with Ind AS prescribed under Section 133 of Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 (as amended), specifically Ind AS 34 "Interim Financial Reporting".